Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

metabolic life style diseases

Total questions: 20

Worksheet time: 7mins

Name
Class
Date
1.

1. Which of the following is NOT a criterion in the NCEP ATP III definition of metabolic syndrome?

a)

Elevated triglycerides

b)

Low HDL cholesterol

c)

Insulin resistance measured by HOMA-IR

d)

Increased waist circumference

2.

. According to IDF criteria, central obesity is:

a)

. Optional criterion

b)

Mandatory criterion

c)

Not considered

d)

Only for men >102 cm waist

3.

Which of the following best describes the pathophysiological driver of metabolic syndrome?

a)

Hyperuricemia

b)

. Insulin resistance

c)

Vitamin D deficiency

d)

Low physical activity alone

4.

The presence of metabolic syndrome increases the risk of:

a)

Stroke by ~2x

b)

Type 2 Diabetes by ~5x

c)

Cardiovascular disease by ~2x

d)

All of the above

5.

Which adipokine is most strongly associated with the pathogenesis of metabolic syndrome?

a)

Leptin

b)

Adiponectin

c)

Ghrelin

d)

. Resistin

6.

. In 2023, the term NAFLD was replaced with:

a)

ALD

b)

MAFLD

c)

. MASLD

d)

NASH only

7.

The gold standard for diagnosis of NASH remains:

a)

Ultrasound

b)

Fibroscan

c)

Liver biopsy

d)

MRI-PDFF

8.

Which of the following is least sensitive for detecting hepatic steatosis?

a)

Ultrasound

b)

. MRI-PDFF

c)

CAP (FibroScan)

d)

Proton MR spectroscopy

9.

9. Which non-invasive score is most validated for fibrosis risk stratification in MASLD?

a)

FIB-4

b)

MELD

c)

APRI

d)

Child-Pugh

10.

Which drug currently has the strongest RCT evidence for biopsy-proven NASH improvement?

a)

Pioglitazone

b)

Metformin

c)

Vitamin E

d)

. Statins

11.

11. Which of the following best defines prediabetes (ADA 2023)?

a)

. FPG 100–125 mg/dL or HbA1c 5.7–6.4%

b)

FPG 110–125 mg/dL or HbA1c 6.0–6.4%

c)

FPG 126–139 mg/dL

d)

OGTT 2h >200 mg/dL

12.

12. According to UKPDS, every 1% reduction in HbA1c reduces microvascular complications by:

a)

5%

b)

15%

c)

. 25%

d)

37%

13.

13. Which agent has the best evidence for cardiovascular risk reduction in T2DM?

a)

Sulfonylureas

b)

GLP-1 receptor agonists

c)

DPP-4 inhibitors

d)

Pioglitazone

14.

14. Which class is most strongly recommended in T2DM with CKD (ADA 2025)?

a)

. SGLT2 inhibitors

b)

Insulin

c)

GLP-1 RA

d)

Sulfonylureas

15.

15. In T2DM, the primary mechanism of metformin is:

a)

. Increased insulin secretion

b)

Reduced hepatic gluconeogenesis

release

c)

C. Increased GLP-1

d)

D. Blocking renal glucose reabsorption

16.

16. The minimum recommended weekly physical activity for adults (WHO 2020):

a)

A. 60 min moderate activity

b)

B. 150–300 min moderate activity

c)

C. 75 min vigorous activity only

d)

D. 60 min daily

17.

17. Which type of exercise has the strongest evidence for insulin sensitivity improvement?

a)

A. Resistance training

b)

B. Aerobic exercise

c)

C. Combined aerobic + resistance

d)

D. Yoga only

18.

18. In patients with fatty liver, weight reduction target for histological improvement:

a)

A. 2–3%

b)

B. 5–7%

c)

C. 10% or more

d)

D. 15%

19.

19. The Mediterranean diet is proven to reduce:

a)

A. Insulin resistance

b)

B. Cardiovascular events

c)

C. Progression of MASLD

d)

D. All of the above

20.

20. The DPP (Diabetes Prevention Program) showed lifestyle modification reduced T2DM risk by:

a)

A. 25%

b)

B. 35%

c)

C. 50%

d)

D. 58%